We are live on
!
Find out more
JLBC
J.L. Bainbridge & Co Portfolio holdings
AUM
$1.27B
1-Year Est. Return
26.55%
This Fund
S&P 500
This Quarter
Est. Return
-16.79%
1 Year Est. Return
+26.55%
3 Year Est. Return
+93.81%
5 Year Est. Return
+120.16%
10 Year Est. Return
–
AUM
$673M
AUM Growth
-$205M
(-23%)
Cap. Flow
-$52.3M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
70.02%
Holding
91
New
2
Increased
28
Reduced
27
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$10.5M |
| 2 |
Amazon
AMZN
|
+$4.93M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.91M |
| 4 |
American Express
AXP
|
+$3.8M |
| 5 |
Comcast
CMCSA
|
+$1.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$45.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$20.9M |
| 3 |
AT&T
T
|
+$7.93M |
| 4 |
Apple
AAPL
|
+$1.46M |
| 5 |
Meta Platforms (Facebook)
META
|
+$886K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.15% |
| 2 | Communication Services | 26.67% |
| 3 | Healthcare | 11.68% |
| 4 | Financials | 6.32% |
| 5 | Consumer Discretionary | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Atossa Therapeutics
ATOS
$25.7M
| $12K | ﹤0.01% |
708
| – | – |
|
77
Autodesk
ADSK
$55B
| – | – |
-980
| Closed | -$210K |
|
78
Broadcom
AVGO
$1.75T
| – | – |
-4,060
| Closed | -$256K |
|
79
Cisco
CSCO
$433B
| – | – |
-4,549
| Closed | -$254K |
|
|
80
CALL
CVS Health
CVS
$119B
| – | – |
-40,000
| Closed | -$4.05M |
|
81
WisdomTree US High Dividend Fund
DHS
$1.6B
| – | – |
-2,306
| Closed | -$203K |
|
82
Emerson Electric
EMR
$86.6B
| – | – |
-2,439
| Closed | -$239K |
|
83
CALL
Gilead Sciences
GILD
$181B
| – | – |
-20,000
| Closed | -$1.19M |
|
|
84
Gilead Sciences
GILD
$181B
| – | – |
-746
| Closed | -$44K |
|
85
Global Payments
GPN
$24.3B
| – | – |
-1,668
| Closed | -$228K |
|
86
3M
MMM
$89.9B
| – | – |
-1,664
| Closed | -$207K |
|
87
Altria Group
MO
$115B
| – | – |
-3,982
| Closed | -$208K |
|
88
Philip Morris
PM
$299B
| – | – |
-2,561
| Closed | -$241K |
|
89
Schwab U.S Small- Cap ETF
SCHA
$22.7B
| – | – |
-8,682
| Closed | -$206K |
|
90
CALL
Target
TGT
$74.1B
| – | – |
-20,000
| Closed | -$4.24M |
|
|
ATRS
91
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-30,000
| Closed | -$123K |
|
Similar funds
KA
BFS
CFM
JMFC
WA
CAM
JTWM
FG
J.L. Bainbridge & Co's Q2 2022 Portfolio in Review
As of Q2 2022, J.L. Bainbridge & Co held 91 positions worth $673M, down 23% from $878M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
J.L. Bainbridge & Co withdrew a net $52.3M in Q2 2022, closing 15 positions and reducing 27 holdings. Its most notable exit was Broadcom, an estimated $256K position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, J.L. Bainbridge & Co opened a new position in Eaton worth $1M.
- J.L. Bainbridge & Co's largest Q2 2022 buy was Eaton: 7,942 shares worth $1M.
- J.L. Bainbridge & Co added most to Warner Bros in Q2 2022, an estimated $10.5M increase.
- J.L. Bainbridge & Co's biggest Q2 2022 reduction was CVS Health, cutting an estimated $45.7M.
- J.L. Bainbridge & Co fully exited Broadcom in Q2 2022, selling an estimated $256K.
- J.L. Bainbridge & Co's ten largest holdings make up 70% of its $673M portfolio in Q2 2022.
- J.L. Bainbridge & Co opened 2 new positions and closed 15 in Q2 2022.
- J.L. Bainbridge & Co's portfolio value fell 23% quarter-over-quarter to $673M.
Based on J.L. Bainbridge & Co's 13F filing for Q2 2022, filed 4 Aug 2022.